Rehab Basel
12
2
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury
Role: collaborator
Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State
Role: collaborator
Inspiratory Strength and Respiratory Complications After SCI Injury
Role: collaborator
Long-term Effects of AAT in Patients With ABI
Role: collaborator
The Prevalence of Malnutrition and Sarcopenia in Swiss Rehabilitation Settings
Role: collaborator
Moderate Intensity Aerobic Training in Sub-acute and Chronic Stroke Patients - the Influence on Brain Derived Neurotrophic Factor (BDNF) and Upper-limb Rehabilitation. A Protocol for a Randomized Control Trial and Health Economic Evaluation
Role: collaborator
Neurovascular Reactions to AAT in Patients With DOC
Role: collaborator
Animal Assisted Mindfulness Intervention (AAMI) for Patients With Acquired Brain Injury
Role: collaborator
Locomotor Training in Individuals With Incomplete Spinal Cord Injury. A Pilot Study
Role: lead
Replacing Canes With an Elasticated Orthosis in Chronic Stroke Patients: The Influence on Gait and Balance. A Series of N-of-1 Trials
Role: collaborator
Effects of Animal Assisted Therapy on Patients With Severe Disorders of Consciousness
Role: collaborator
Neurofeedback in Patients With Frontal Brain Lesions
Role: collaborator
All 12 trials loaded